172 related articles for article (PubMed ID: 34594585)
1. A Case of Endometrial Carcinosarcoma Containing Sertoliform Endometrioid Carcinoma Component.
Munakata S; Kushibiki H; Akimoto T; Yamashita T; Shimoyama N
Case Rep Pathol; 2021; 2021():5868818. PubMed ID: 34594585
[TBL] [Abstract][Full Text] [Related]
2. Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review.
Liang SX; Patel K; Pearl M; Liu J; Zheng W; Tornos C
Int J Gynecol Pathol; 2007 Jul; 26(3):291-7. PubMed ID: 17581414
[TBL] [Abstract][Full Text] [Related]
3. Sertoliform endometrial adenocarcinoma: a study of four cases.
Eichhorn JH; Young RH; Clement PB
Int J Gynecol Pathol; 1996 Apr; 15(2):119-26. PubMed ID: 8786200
[TBL] [Abstract][Full Text] [Related]
4. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms.
Murray SK; Clement PB; Young RH
Am J Surg Pathol; 2005 Feb; 29(2):157-66. PubMed ID: 15644772
[TBL] [Abstract][Full Text] [Related]
5. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases.
Ordi J; Schammel DP; Rasekh L; Tavassoli FA
Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556
[TBL] [Abstract][Full Text] [Related]
6. Folate Receptor Alpha Is Preferentially Expressed in the Carcinoma Component of Endometrial Carcinosarcomas: A Potential Target for Adjuvant Therapy.
Hanley KZ; Horowitz IR; Gordon A; Meisel J; Khanna N
Int J Gynecol Pathol; 2021 Sep; 40(5):501-509. PubMed ID: 33323854
[TBL] [Abstract][Full Text] [Related]
7. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
[TBL] [Abstract][Full Text] [Related]
8. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
9. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
10. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
11. Expression of adhesion molecules and the proliferative activity of carcinosarcoma of the ovary.
Hirano H; Kizaki T; Ito T; Okimura A; Yamanegi K; Nakasho K
Anticancer Res; 2014 Dec; 34(12):7351-6. PubMed ID: 25503171
[TBL] [Abstract][Full Text] [Related]
12. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
[TBL] [Abstract][Full Text] [Related]
14. Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas.
Mirkovic J; Olkhov-Mitsel E; Amemiya Y; Al-Hussaini M; Nofech-Mozes S; Djordjevic B; Kupets R; Seth A; McCluggage WG
Histopathology; 2023 Jun; 82(7):978-990. PubMed ID: 36860193
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
16. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
17. Cytological features of uterine carcinosarcoma: A retrospective study of 20 cases with an emphasis on the usefulness of endometrial cytology.
Okano K; Ishida M; Sandoh K; Mizokami T; Kita M; Okada H; Tsuta K
Diagn Cytopathol; 2019 Jun; 47(6):547-552. PubMed ID: 30706679
[TBL] [Abstract][Full Text] [Related]
18. Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas.
Tessier-Cloutier B; Soslow RA; Stewart CJR; Köbel M; Lee CH
Histopathology; 2018 Aug; 73(2):299-305. PubMed ID: 29671892
[TBL] [Abstract][Full Text] [Related]
19. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
McCluggage WG; Sumathi VP; Maxwell P
Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
[TBL] [Abstract][Full Text] [Related]
20. Sertoliform endometrioid carcinoma of the right ovary.
Alali M; Hajji S; Aljenaee K
Endocrinol Diabetes Metab Case Rep; 2023 Jul; 2023(3):. PubMed ID: 37767716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]